ARTICLE | Clinical News
INS37217 denufosol tetrasodium: Phase II start
May 2, 2005 7:00 AM UTC
ISPH will start this quarter an open-label, U.S. Phase II trial in about 15 patients with uveitis. ...
Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
ISPH will start this quarter an open-label, U.S. Phase II trial in about 15 patients with uveitis. ...